Cancer treatment center uncovers promising advancement with stem cell transplantation technique.
Rewrite
Rajavithi Hospital recently made history by performing the first-ever stem cell transplantation on a 60-year-old patient with multiple myeloma, a type of cancer. This breakthrough marks a significant leap forward in the hospital's mission to revolutionize life-saving medical technology.
Dr Jinda Rojanamatin, the hospital's director, spilled the beans on this groundbreaking achievement at a recent press conference. The multidisciplinary team of medical professionals collaborated to carry out a haematopoietic stem cell transplantation (HSCT) on the patient, who had been suffering from severe spinal pain. The diagnosis revealed multiple myeloma, a cancer that originates from plasma cells in the bone marrow.
The team first administered chemotherapy, resulting in a Very Good Partial Response (VGPR). Following the initial treatment, they proceeded with advanced therapy involving stem cell collection. The team successfully harvested an impressive 11.21 million cells per kilogramme from the patient.
On February 16, the collected healthy cells were reintroduced to the patient through an autologous haematopoietic stem cell transplantation. Within nine days, the patient demonstrated remarkable signs of recovery without any complications and responded vigorously to the treatment, as indicated by the hospital.
Multiple myeloma is characterized by the excessive proliferation of plasma cells, which triggers high protein levels in the blood. This condition often leads to bone pain, fractures, kidney failure, and elevated calcium levels.
"Haematopoietic stem cell transplantation not only increases the survival chances but also offers a more efficient treatment approach," asserted Dr Jinda.
Autologous stem cell transplants involve utilizing a patient's own blood stem cells to replace damaged bone marrow. By using the patient's own cells, potential compatibility issues and rejection risks commonly associated with donor transplants are minimized.
The successful outcome of this stem cell transplantation sets the stage for Rajavithi Hospital to provide state-of-the-art treatment for patients battling complex diseases.
Based on available information, the hospital's first documented stem cell transplantation involved a 60-year-old multiple myeloma patient using the autologous HSCT method. The patient experienced rapid recovery within nine days with no complications, demonstrating the effectiveness of this treatment approach. However, further cases may require consultation with hospital records or newer publications for detailed insights.
Though details about other specific stem cell transplant cases at Rajavithi Hospital are scarce, the hospital's ongoing participation in complex medical cases involving transplant-related complications suggests continued capability in this field. Nonetheless, these incidents reflect broader clinical activities rather than specific transplant outcomes.
- Rajavithi Hospital's autologous haematopoietic stem cell transplantation (HSCT) approach was employed to treat a 60-year-old patient suffering from multiple myeloma, a cancer originating from plasma cells in the bone marrow.
- The recovery of the patient, who demonstrated remarkable signs of improvement within nine days with no complications, underscores the effectiveness of the HSCT in tackling health-and-wellness issues like multiple myeloma.
- The success of this treatment offers a more efficient approach to addressing multiple-sclerosis and other neurological-disorders, further solidifying Rajavithi Hospital's commitment to science, health-and-wellness, therapies-and-treatments, and medical-conditions.
- Harnessing the potential of autologous stem cell transplants, the hospital's multidisciplinary team of medical professionals aims to revolutionize the treatment of life-threatening medical conditions, fostering a culture of innovation in stem cell research and treatment.
- By utilizing a patient's own blood stem cells, autologous stem cell transplants minimize compatibility issues and rejection risks commonly associated with donor transplants, ensuring a more promising prognosis for patients with various medical-conditions such as multiple myeloma.
- Rajavithi Hospital's pioneering work in stem cell transplantation, starting with the documented case involving a multiple myeloma patient, signifies a significant leap forward in the realm of science and medicine, offering hope for those battling complex diseases and paving the way for future developments in medical-technology.
